Back to Search
JULIE MARIS, PHARMD
PHARMD
Pharmacist
NPI: 1508193004Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
47950(TX)
Research & Publications (20)
Comparison of primary neuroblastoma tumors and derivative early-passage cell lines using genome-wide single nucleotide polymorphism array analysis.
PMID 19435921·Cancer Res·2009
8-other
Common variations in BARD1 influence susceptibility to high-risk neuroblastoma.
PMID 19412175·Nat Genet·2009
8-other
Initial testing (stage 1) of the kinesin spindle protein inhibitor ispinesib by the pediatric preclinical testing program.
PMID 19554570·Pediatr Blood Cancer·2009
7-preclinical
Clinicopathological characteristics of ganglioneuroma and ganglioneuroblastoma: a report from the CCG and COG.
PMID 19530234·Pediatr Blood Cancer·2009
8-other
Initial testing of aplidin by the pediatric pre-clinical testing program.
PMID 19418543·Pediatr Blood Cancer·2009
7-preclinical
International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee.
PMID 19401703·Br J Cancer·2009
8-other
Iodine-131--metaiodobenzylguanidine double infusion with autologous stem-cell rescue for neuroblastoma: a new approaches to neuroblastoma therapy phase I study.
PMID 19171714·J Clin Oncol·2009
3-trial
Initial testing (stage 1) of vorinostat (SAHA) by the pediatric preclinical testing program.
PMID 19418547·Pediatr Blood Cancer·2009
7-preclinical
Phase I trial of oral irinotecan and temozolomide for children with relapsed high-risk neuroblastoma: a new approach to neuroblastoma therapy consortium study.
PMID 19171709·J Clin Oncol·2009
3-trial
Genomic copy number determination in cancer cells from single nucleotide polymorphism microarrays based on quantitative genotyping corrected for aneuploidy.
PMID 19141597·Genome Res·2009
4-observational
Unholy matrimony: Aurora A and N-Myc as malignant partners in neuroblastoma.
PMID 19111875·Cancer Cell·2009
7-preclinical
Outcome of high-risk stage 3 neuroblastoma with myeloablative therapy and 13-cis-retinoic acid: a report from the Children's Oncology Group.
PMID 18937318·Pediatr Blood Cancer·2009
3-trial
Initial testing (stage 1) of lapatinib by the pediatric preclinical testing program.
PMID 19554571·Pediatr Blood Cancer·2009
7-preclinical
External fixation and pseudoaneurysm: report of a case related to tibial lengthening.
PMID 19225998·Orthopedics·2008
5-case
Adjustment of genomic waves in signal intensities from whole-genome SNP genotyping platforms.
PMID 18784189·Nucleic Acids Res·2008
8-other
High Myc pathway activity and low stage of neuronal differentiation associate with poor outcome in neuroblastoma.
PMID 18780787·Proc Natl Acad Sci U S A·2008
8-other
Identification of ALK as a major familial neuroblastoma predisposition gene.
PMID 18724359·Nature·2008
8-other
Hepatic absorbed radiation dosimetry during I-131 metaiodobenzylguanidine (MIBG) therapy for refractory neuroblastoma.
PMID 18682939·Eur J Nucl Med Mol Imaging·2008
3-trial
Cortical processing of respiratory occlusion stimuli in children with central hypoventilation syndrome.
PMID 18658113·Am J Respir Crit Care Med·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1902 RICHMOND RD
TEXARKANA, TX 75503 - Phone
- (903) 838-3988
Quick Facts
- NPI
- 1508193004
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile